Brief: Prometheus Biosciences Plans To File IND For PRA052 In Q3

Prometheus Biosciences

26/07/2022 23:13

July 26 (Reuters) - Prometheus Biosciences Inc  RXDX.O :
    * PROMETHEUS BIOSCIENCES INC - PLANS TO FILE AN
INVESTIGATIONAL
NEW DRUG APPLICATION ("IND") FOR PRA052 IN Q3 OF 2022
    * PROMETHEUS BIOSCIENCES - TO ADVANCE PRA052 INTO PHASE 1
SINGLE
ASCENDING DOSE/MULTIPLE ASCENDING DOSE TRIAL IN NORMAL HEALTHY
VOLUNTEERS IN Q4 2022
    * PROMETHEUS BIOSCIENCES INC - DEVELOPING A PROPRIETARY
COMPANION
DIAGNOSTIC GENETIC TEST FOR PRA052

Source text for Eikon: [https://bit.ly/3OBrF6L]
Further company coverage:  RXDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))